Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

BUY
$278.73 - $327.27 $4.61 Million - $5.41 Million
16,539 New
16,539 $5.32 Million
Q1 2021

May 03, 2021

SELL
$164.32 - $212.72 $4.74 Million - $6.13 Million
-28,816 Closed
0 $0
Q4 2020

Jan 25, 2021

BUY
$130.46 - $172.63 $162,553 - $215,096
1,246 Added 4.52%
28,816 $4.87 Million
Q2 2020

Jul 28, 2020

BUY
$136.42 - $164.18 $3.76 Million - $4.53 Million
27,570 New
27,570 $4.53 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD Portfolio

Follow Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD, based on Form 13F filings with the SEC.

News

Stay updated on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD with notifications on news.